Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,18 USD | +0,24% | -7,11% | +182,43% |
Omzet 2024 * | 242K 227K | Omzet 2025 * | 66,67K 62,28K | Marktkapitalisatie | 187 mln. 174 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -46 mln. -42,97 mln. | Nettowinst (verlies) 2025 * | -57 mln. -53,24 mln. | EV/omzet 2024 * | 770 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2.801 x |
K/w-verhouding 2024 * |
-4,29
x | K/w-verhouding 2025 * |
-3,97
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,32% |
Recentste transcriptie over Cardiff Oncology, Inc.
1 dag | +0,24% | ||
1 week | -7,11% | ||
Lopende maand | -21,72% | ||
1 maand | -28,55% | ||
3 maanden | +175,91% | ||
6 maanden | +335,42% | ||
Lopend jaar | +182,43% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark Erlander
CEO | Chief Executive Officer | 64 | 04-03-13 |
James Levine
DFI | Director of Finance/CFO | 53 | 12-07-21 |
Tod Smeal
CTO | Chief Tech/Sci/R&D Officer | 59 | 11-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Armitage
BRD | Director/Board Member | 77 | 22-04-20 |
Gary Pace
BRD | Director/Board Member | 76 | 22-04-20 |
Mark Erlander
CEO | Chief Executive Officer | 64 | 04-03-13 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 4,18 | +0,24% | 343 293 |
23-04-24 | 4,17 | -4,36% | 702 313 |
22-04-24 | 4,36 | +0,23% | 462 511 |
19-04-24 | 4,35 | -0,46% | 608 535 |
18-04-24 | 4,37 | -2,89% | 832 218 |
uitgestelde koers Nasdaq, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+182,43% | 186 mln. | |
+4,09% | 43,43 mld. | |
+47,81% | 41,69 mld. | |
+9,45% | 41,31 mld. | |
-10,92% | 27,14 mld. | |
+9,32% | 25,28 mld. | |
-24,87% | 18,47 mld. | |
+29,70% | 12,59 mld. | |
+1,28% | 12,33 mld. | |
+7,78% | 11,03 mld. |